FDA warns cucumber growers about violations of federal law that led to Salmonella outbreak
In a Nov. 17 warning letter the Food and Drug Administration outlined problems at Bedner Growers Inc. of Boynton Beach, FL, which is the company that sold cucumbers traced to outbreaks of Salmonella infections in 2024 and 2025. The agency found that the grower was in violation of federal law.
The FDA conducted an inspection of the company’s farm from April 1, 2025, through April 3, 2025, in response to the 2024 multi-state outbreak of human infections with Salmonella Africana and Salmonella Braenderup during which FDA also conducted an inspection of your farm from June 5, 2024, through June 7, 2024.
As described below, based on the 2024 and 2025 multi-state outbreak investigations of Salmonella linked to cucumbers from your farm, and positive environmental and product samples containing multiple strains of Salmonella, the cucumbers you grow and pack are adulterated in that they were prepared, packed, or held under insanitary conditions whereby they may have become contaminated with Salmonella, a human pathogen. Further, based on analytical results of cucumbers collected by FDA on May 15, 2025, FDA determined that your cucumbers are adulterated in that your cucumbers yielded multiple strains of Salmonella, and these cucumbers were shipped in interstate commerce.
After the inspection of your farm, FDA notified you of sample results on April 16, April 21, and April 29, 2025. We received your written responses on May 16, 2025, and June 25, 2025, describing your corrective actions. We address your written responses below.
2025 inspection
On April 2, 2025, FDA collected a sample consisting of (redacted) environmental swabs from your cucumber packing line. FDA analyzed the sample and determined that (redacted) of the (redacted) swabs, representing food contact surfaces, were positive for Salmonella. Whole Genome Sequencing (WGS) analysis revealed that, as of May 7, 2025, (redacted) isolates matched (redacted) 2025 clinical isolates in the National Center for Biotechnology Information’s database. The same (redacted) isolates from the sample were pathogens associated with illness in the 2025 multi-state outbreak investigation of human infections with Salmonella Montevideo.
2025 multi-state outbreak
The FDA and the Centers for Disease Control and Prevention, in collaboration with state and local partners, investigated illnesses in a multistate outbreak of Salmonella Montevideo infections. CDC’s epidemiologic investigation concluded that cucumbers were the outbreak vehicle. FDA’s traceback investigation determined cucumbers grown at your farm were the source the outbreak illnesses. As of May 30, 2025, forty-five people from eighteen states were infected with the outbreak strain, and sixteen people were hospitalized.
As part of FDA’s investigation, on May 15, 2025, FDA collected sample cucumbers determined to have been grown at your farm, from a distribution center in Pennsylvania. Salmonella was detected and WGS analysis determined that two isolates from this sample matched the Salmonella Montevideo outbreak strain.
In addition, multiple other strains of Salmonella were detected which matched other isolates in the National Center for Biotechnology Information’s database, including isolates from a 2024 multistate outbreak of human infections with Salmonella Africana and Salmonella Braenderup, and an isolate from a 2024 cucumber sample collected by the Pennsylvania Department of Agriculture, which was also determined to have been grown at your farm.
FDA’s evaluation of your written responses
On May 16, 2025, FDA received your written response, describing corrective actions taken by your farm since April 14, 2025. We note that your written response lacked supporting details, or evidence of implementation, except for a letter from the University of Florida, dated May 12, 2025, which describes the third-party sampling effort that occurred at your farm on April 16, 2025.
As such, we note the following:
You stated that you have conducted environmental samples which include soil samples, leaf tissue samples, equipment samples, product samples and water samples. The collection method, lab analysis method, and results were not provided. You did not provide information regarding when these samples were collected, what your rationale was for collecting them, what steps you would have taken depending on the analysis outcome, and if sampling will continue during the 2026 growing and harvesting season as part of your farm’s effort to “(redacted).” We are unable to determine the adequacy of these corrective actions.
You provided a letter from the University of Florida, dated May 12, 2025, which describes the third party sampling effort that occurred at your farm on April 16, 2025. We recognize that these swabs were collected after the cucumber line had been cleaned and sanitized. You did not provide information regarding how the cucumber line was cleaned and sanitized, or if the sanitation protocol used was representative of a routine cleaning, or representative of what will occur during the next growing and harvesting season. You did not provide information regarding whether cucumbers were processed on the cucumber line prior to cleaning it, and if the quantity of cucumbers were representative of a normal production run.
You also stated that, (redacted) on your cucumber line, (redacted). No additional supportive documentation was provided. Our findings of Salmonella on food contact surfaces of your cucumber packing line, as well as on cucumbers grown at your farm, after your corrective actions were taken, demonstrate that your corrective actions were not adequate.
You stated that (redacted). We will verify these corrections during a follow-up inspection of your farm.
You stated that you (redacted). You did not provide your rationale for this change, how you have implemented this change, and how you have trained your employees based on this change. We will verify these corrections during a follow-up inspection of your farm.
You referenced a “(redacted)” and “(redacted)” in your written response. These documents were not received so we cannot further evaluate these documents or the subsequent implementation. We will verify these actions during a follow-up inspection of your farm.
In addition, on June 25, 2025, FDA received a letter from you titled noting that your 2025 season has ended, that you will not be renewing your land leases for 2026, and that you will not be growing produce for wholesale distribution. You did not provide information regarding whether you will continue to grow on land that is not leased (other properties), whether your land leases could potentially be renewed after 2026, whether you will continue to grow for retail distribution, or what your plans are for your cucumber packing line, where we detected the 2025 outbreak strain of Salmonella Montevideo. FDA cannot assess the scope or impact of your future operations based on the limited information provided in your letter. Regardless of your stated intentions, you must ensure that any continuing business operations comply with all applicable requirements of the Produce Safety Rule and the Act.
The full warning letter is available here.
Source: https://www.foodsafetynews.com/2025/12/fda-warns-cucumber-growers-about-violations-of-federal-law-that-led-to-salmonella-outbreak/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

